ID

5593

Description

see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Lien

http://clinicaltrials.gov/ct2/show/record/NCT00617669

Mots-clés

  1. 15/11/2011 15/11/2011 -
  2. 23/03/2014 23/03/2014 - Martin Dugas
  3. 10/08/2014 10/08/2014 - Martin Dugas
  4. 13/04/2021 13/04/2021 - Dr. rer. medic Philipp Neuhaus
  5. 20/09/2021 20/09/2021 -
  6. 28/09/2021 28/09/2021 - Sarah Riepenhausen
Téléchargé le

10 août 2014

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility DRKS00005404 NCT00617669 Prostate Cancer

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Description

Age

Type de données

integer

Unités de mesure
  • years
Alias
UMLS CUI-1
C0001779
years
male
Description

Gender Male

Type de données

boolean

Alias
UMLS CUI-1
C0024554
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
Description

Prostate Cancer with bone metastasis

Type de données

boolean

Alias
UMLS CUI-1
C0600139
UMLS CUI-2
C0153690
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Description

PSA increase

Type de données

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Description

Castration

Type de données

boolean

Alias
UMLS CUI-1
C0007347
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Description

Previous chemotherapy

Type de données

boolean

Alias
UMLS CUI-1
C0205156
UMLS CUI-2
C0392920
Suffering from heart failure or had a myocardial infarction within last 6 months
Description

Heart disease

Type de données

boolean

Alias
UMLS CUI-1
C0018801
UMLS CUI-2
C0155626
A history of epilepsy or seizures
Description

Epilepsy, seizures

Type de données

boolean

Alias
UMLS CUI-1
C0014544
UMLS CUI-2
C0036572

Similar models

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
integer
C0001779 (UMLS CUI-1)
Gender Male
Item
male
boolean
C0024554 (UMLS CUI-1)
Prostate Cancer with bone metastasis
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
boolean
C0600139 (UMLS CUI-1)
C0153690 (UMLS CUI-2)
PSA increase
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C0205156 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018801 (UMLS CUI-1)
C0155626 (UMLS CUI-2)
Epilepsy, seizures
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)
C0036572 (UMLS CUI-2)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial